- Surface chemistry company AnteoTech (ADO) has received official certification as a legal manufacturer of medical devices
- As in many industries, the return on refined goods is higher than that of raw materials
- AnteoTech's new certification will allow it to enjoy better returns as a provider of both raw materials and end-to-end solutions
- The company also believes the new certification will help the company gain prominence and visibility in the medical manufacturing space
- AnteoTech is up 7.14 per cent to six cents
Surface chemistry company AnteoTech (ADO) has received official certification as a legal manufacturer of medical devices.
The ISO-13485 certification completes a long program of work to attain regulatory approval as an approved assay developer for medical testing.
Value adding
As in many industries, the return on refined goods is higher than that of raw materials.
AnteoTech's previous focus on the chemistry of raw materials will remain a part of the business. But the company's new certification, as an assay developer and manufacturer of medical devices, will allow it to enjoy better returns.
AnteoTech CEO Derek Thomson says the certification is an important step up for the company.
"ISO-13485 certification is the final element completing AnteoTech’s progression to a position that will allow us to launch our own assays into the market and we are delighted to have achieved this key milestone," Derek said.
"The Life Science business now has a platform from which to leverage new revenue and growth and we are working very hard to exploit this opportunity starting with developing and owning a highly sensitive COVID-19 antigen rapid test which we aim to be our first assay product in the market.”
Next steps
Just yesterday, AnteoTech announced positive results from product verification trials of its COVID-19 antigen rapid test.
As a certified manufacturer, AnteoTech can not only accelerate production of its own novel devices, but support other assay developers. By offering either discrete elements of the development process or an end-to-end complete assay development service, the company will be adding value to its intellectual property portfolio.
According to AnteoTech, the new certification will also help the company gain prominence and visibility in the medical manufacturing space.
AnteoTech believes being able to supply anything from raw materials to end-to-end solutions will enable the company to see more revenues across a more diverse portfolio.
AnteoTech is up 7.14 per cent to six cents at 1:04 pm AEST.
